| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.0023 | 0.9 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |